Related Experiment Video
Updated: Mar 31, 2026

A New Murine Model of Endovascular Aortic Aneurysm Repair
Published on: July 7, 2013
Systemic Inflammatory Disease and Its Association With Type II Endoleak and Late Interventions After Endovascular
Sherif Y Shalaby1, Trenton R Foster1, Michael R Hall1
1Department of Surgery, VA Connecticut Healthcare System, West Haven2Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.
Importance:
Abdominal aortic aneurysms are associated with chronic inflammation within the aortic wall, and previous studies have suggested that chronic inflammation may be a consequence of a dysregulated and persistent autoimmune response. Persistent aortic remodeling after aneurysm repair could place the patient at risk for endoleak or sac rupture.
Objective:
To determine whether patients with systemic inflammatory disease and large aneurysms have persistent aortic remodeling after endovascular aneurysm repair (EVAR).
Design, Setting, And Participants:
The records of all patients who underwent EVAR between July 2002 and June 2011 at the Veterans Affairs Connecticut Healthcare System were included in this retrospective review. Patients were considered to have a systemic inflammatory disease when confirmed by a referring specialist. Post-EVAR surveillance was performed by yearly imaging.
Intervention:
Endovascular aneurysm repair.
Main Outcomes And Measures:
Significant endoleak, defined as endoleak and sac diameter increase of 0.5 cm or greater.
Results:
A total of 51 of 79 patients (65%) had a systemic inflammatory disease. These patients had similar comorbid conditions compared with patients without inflammation but significantly greater numbers of major postoperative complications after EVAR (23.5% vs 3.6%; P = .02) and overall postoperative complications after EVAR (27.5% vs 7.1%; P = .03). Patients with a history of systemic inflammatory disease developed more endoleaks (45.1% vs 17.9%; P = .02) and late sac expansion (51.0% vs 21.4%; P = .01) and required more interventions (21.6% vs 3.6%; P = .03) during long-term follow-up. Systemic inflammatory disease was significantly associated with significant endoleak (odds ratio, 5.18; 95% CI, 1.56-17.16; P = .007).
Conclusions And Relevance:
Patients with systemic inflammatory disease are at high risk for postoperative complications, type II endoleak, sac expansion, and additional interventions after EVAR. Additional strategies for improving the efficacy of EVAR in these patients may be warranted.
More Related Videos
Related Concept Videos
Aneurysm III: Interprofessional Care
Endocarditis III: Medical Management
Endocarditis I: Introduction
Aneurysm IV: Nursing Management
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis

